According to a press release by Incyte, The U.S. Food and Drug Administration has granted approval for a topical treatment for vitiligo in patients 12 and older. The Delaware-based pharmaceutical company announced on Monday that its Opzelura cream, known as Ruxolitinib, is the first FDA-approved treatment for repigmentation in patients with nonsegmental vitiligo, the most…
Read More
This past Monday, June 15, 2020, The Food and Drug Administration revoked an emergency approval for the use of the malaria drug hydroxychloroquine as a Covid-19 treatment stating that it is “unlikely to be effective in treating Covid-19,” warning against “serious side effects.” The withdrawal is because specific and conclusive research has shown that the…
Read More
There’s been a bit of a controversy over at the FDA regarding a certain ingredient in some dietary supplements. It’s Phenibut, an ingredient in sleep aids. Apparently, it no longer fits in with all the other ingredients that are allowed to go into dietary supplements. It’s a good old fashioned case of “one of…
Read More
A new study was released by JAMA showing that 32% of medications are found to have significant safety risks only after the drugs are released to the market. “The researchers reviewed 222 products approved between 2001 and 2010 and followed them through February of this year. In 32 percent of the medications, they found, the…
Read More